Cargando…

Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

The tumor microenvironment (TME) is known to have a strong influence on tumorigenesis, with various components being involved in tumor suppression and tumor growth. A protumorigenic TME is characterized by an increased infiltration of tumor associated macrophages (TAMs), where their presence is stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hourani, Tetiana, Holden, James A., Li, Wenyi, Lenzo, Jason C., Hadjigol, Sara, O’Brien-Simpson, Neil M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722774/
https://www.ncbi.nlm.nih.gov/pubmed/34988021
http://dx.doi.org/10.3389/fonc.2021.788365
_version_ 1784625584427499520
author Hourani, Tetiana
Holden, James A.
Li, Wenyi
Lenzo, Jason C.
Hadjigol, Sara
O’Brien-Simpson, Neil M.
author_facet Hourani, Tetiana
Holden, James A.
Li, Wenyi
Lenzo, Jason C.
Hadjigol, Sara
O’Brien-Simpson, Neil M.
author_sort Hourani, Tetiana
collection PubMed
description The tumor microenvironment (TME) is known to have a strong influence on tumorigenesis, with various components being involved in tumor suppression and tumor growth. A protumorigenic TME is characterized by an increased infiltration of tumor associated macrophages (TAMs), where their presence is strongly associated with tumor progression, therapy resistance, and poor survival rates. This association between the increased TAMs and poor therapeutic outcomes are stemming an increasing interest in investigating TAMs as a potential therapeutic target in cancer treatment. Prominent mechanisms in targeting TAMs include: blocking recruitment, stimulating repolarization, and depletion methods. For enhancing targeting specificity multiple nanomaterials are currently being explored for the precise delivery of chemotherapeutic cargo, including the conjugation with TAM-targeting peptides. In this paper, we provide a focused literature review of macrophage biology in relation to their role in tumorigenesis. First, we discuss the origin, recruitment mechanisms, and phenotypic diversity of TAMs based on recent investigations in the literature. Then the paper provides a detailed review on the current methods of targeting TAMs, including the use of nanomaterials as novel cancer therapeutics.
format Online
Article
Text
id pubmed-8722774
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87227742022-01-04 Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting Hourani, Tetiana Holden, James A. Li, Wenyi Lenzo, Jason C. Hadjigol, Sara O’Brien-Simpson, Neil M. Front Oncol Oncology The tumor microenvironment (TME) is known to have a strong influence on tumorigenesis, with various components being involved in tumor suppression and tumor growth. A protumorigenic TME is characterized by an increased infiltration of tumor associated macrophages (TAMs), where their presence is strongly associated with tumor progression, therapy resistance, and poor survival rates. This association between the increased TAMs and poor therapeutic outcomes are stemming an increasing interest in investigating TAMs as a potential therapeutic target in cancer treatment. Prominent mechanisms in targeting TAMs include: blocking recruitment, stimulating repolarization, and depletion methods. For enhancing targeting specificity multiple nanomaterials are currently being explored for the precise delivery of chemotherapeutic cargo, including the conjugation with TAM-targeting peptides. In this paper, we provide a focused literature review of macrophage biology in relation to their role in tumorigenesis. First, we discuss the origin, recruitment mechanisms, and phenotypic diversity of TAMs based on recent investigations in the literature. Then the paper provides a detailed review on the current methods of targeting TAMs, including the use of nanomaterials as novel cancer therapeutics. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8722774/ /pubmed/34988021 http://dx.doi.org/10.3389/fonc.2021.788365 Text en Copyright © 2021 Hourani, Holden, Li, Lenzo, Hadjigol and O’Brien-Simpson https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hourani, Tetiana
Holden, James A.
Li, Wenyi
Lenzo, Jason C.
Hadjigol, Sara
O’Brien-Simpson, Neil M.
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title_full Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title_fullStr Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title_full_unstemmed Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title_short Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
title_sort tumor associated macrophages: origin, recruitment, phenotypic diversity, and targeting
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722774/
https://www.ncbi.nlm.nih.gov/pubmed/34988021
http://dx.doi.org/10.3389/fonc.2021.788365
work_keys_str_mv AT houranitetiana tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting
AT holdenjamesa tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting
AT liwenyi tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting
AT lenzojasonc tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting
AT hadjigolsara tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting
AT obriensimpsonneilm tumorassociatedmacrophagesoriginrecruitmentphenotypicdiversityandtargeting